Details
| Stereochemistry | ACHIRAL |
| Molecular Formula | C7H7NO2 |
| Molecular Weight | 137.136 |
| Optical Activity | NONE |
| Defined Stereocenters | 0 / 0 |
| E/Z Centers | 0 |
| Charge | 0 |
SHOW SMILES / InChI
SMILES
OC(=O)CC1=CN=CC=C1
InChI
InChIKey=WGNUNYPERJMVRM-UHFFFAOYSA-N
InChI=1S/C7H7NO2/c9-7(10)4-6-2-1-3-8-5-6/h1-3,5H,4H2,(H,9,10)
| Molecular Formula | C7H7NO2 |
| Molecular Weight | 137.136 |
| Charge | 0 |
| Count |
|
| Stereochemistry | ACHIRAL |
| Additional Stereochemistry | No |
| Defined Stereocenters | 0 / 0 |
| E/Z Centers | 0 |
| Optical Activity | NONE |
Approval Year
PubMed
| Title | Date | PubMed |
|---|---|---|
| An analytical method for the measurement of acid metabolites of tryptophan-NAD pathway and related acids in urine. | 2010-04-15 |
|
| CYP17 blockade by abiraterone: further evidence for frequent continued hormone-dependence in castration-resistant prostate cancer. | 2009-03-10 |
|
| Reaction of the tobacco alkaloid myosmine with hydrogen peroxide. | 2006-01 |
|
| Metabolism of myosmine in Wistar rats. | 2005-11 |
|
| Hormonal impact of the 17alpha-hydroxylase/C(17,20)-lyase inhibitor abiraterone acetate (CB7630) in patients with prostate cancer. | 2004-06-14 |
|
| Molecular identification of high and low affinity receptors for nicotinic acid. | 2003-03-14 |
| Substance Class |
Chemical
Created
by
admin
on
Edited
Mon Mar 31 21:09:23 GMT 2025
by
admin
on
Mon Mar 31 21:09:23 GMT 2025
|
| Record UNII |
7UFO07435N
|
| Record Status |
Validated (UNII)
|
| Record Version |
|
-
Download
| Name | Type | Language | ||
|---|---|---|---|---|
|
Systematic Name | English | ||
|
Preferred Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Systematic Name | English | ||
|
Systematic Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Systematic Name | English | ||
|
Systematic Name | English | ||
|
Code | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Systematic Name | English |
| Code System | Code | Type | Description | ||
|---|---|---|---|---|---|
|
501-81-5
Created by
admin on Mon Mar 31 21:09:23 GMT 2025 , Edited by admin on Mon Mar 31 21:09:23 GMT 2025
|
PRIMARY | |||
|
DTXSID3060110
Created by
admin on Mon Mar 31 21:09:23 GMT 2025 , Edited by admin on Mon Mar 31 21:09:23 GMT 2025
|
PRIMARY | |||
|
108
Created by
admin on Mon Mar 31 21:09:23 GMT 2025 , Edited by admin on Mon Mar 31 21:09:23 GMT 2025
|
PRIMARY | |||
|
7UFO07435N
Created by
admin on Mon Mar 31 21:09:23 GMT 2025 , Edited by admin on Mon Mar 31 21:09:23 GMT 2025
|
PRIMARY | |||
|
3505
Created by
admin on Mon Mar 31 21:09:23 GMT 2025 , Edited by admin on Mon Mar 31 21:09:23 GMT 2025
|
PRIMARY | |||
|
m9352
Created by
admin on Mon Mar 31 21:09:23 GMT 2025 , Edited by admin on Mon Mar 31 21:09:23 GMT 2025
|
PRIMARY | Merck Index | ||
|
207-928-7
Created by
admin on Mon Mar 31 21:09:23 GMT 2025 , Edited by admin on Mon Mar 31 21:09:23 GMT 2025
|
PRIMARY |
| Related Record | Type | Details | ||
|---|---|---|---|---|
|
PARENT -> IMPURITY | |||
|
PARENT -> IMPURITY |
